Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Med Care. 2016 Jul;54(7):725–732. doi: 10.1097/MLR.0000000000000549

Figure 3.

Figure 3

Trajectories of Physician Adoption of Dabigatran in the First 15 Months Postmarket (N=3,911)

Note: In the legend, the values in parenthesis are the number and proportion of physicians in each trajectory group. The output represents predicated average monthly share for dabigatran prescriptions.